Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more
Market Cap & Net Worth: Medical Developments International Limited (MDDVF)
Medical Developments International Limited (PINK:MDDVF) has a market capitalization of $57.19 Million ($57.19 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #22481 globally and #7951 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medical Developments International Limited's stock price $0.51 by its total outstanding shares 112658324 (112.66 Million).
Medical Developments International Limited Market Cap History: 2020 to 2025
Medical Developments International Limited's market capitalization history from 2020 to 2025. Data shows change from $574.56 Million to $57.19 Million (-38.71% CAGR).
Medical Developments International Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medical Developments International Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.46x
Medical Developments International Limited's market cap is 1.46 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
608.35x
Medical Developments International Limited's market cap is 608.35 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $574.56 Million | $22.54 Million | $379.00K | 25.50x | 1515.98x |
| 2021 | $423.60 Million | $25.27 Million | -$12.56 Million | 16.76x | N/A |
| 2022 | $197.15 Million | $21.94 Million | -$12.41 Million | 8.98x | N/A |
| 2023 | $52.87 Million | $32.34 Million | -$5.61 Million | 1.63x | N/A |
| 2024 | $38.98 Million | $33.15 Million | -$40.99 Million | 1.18x | N/A |
| 2025 | $57.19 Million | $39.06 Million | $94.00K | 1.46x | 608.35x |
Competitor Companies of MDDVF by Market Capitalization
Companies near Medical Developments International Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Medical Developments International Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Medical Developments International Limited Historical Marketcap From 2020 to 2025
Between 2020 and today, Medical Developments International Limited's market cap moved from $574.56 Million to $ 57.19 Million, with a yearly change of -38.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $57.19 Million | +46.71% |
| 2024 | $38.98 Million | -26.27% |
| 2023 | $52.87 Million | -73.18% |
| 2022 | $197.15 Million | -53.46% |
| 2021 | $423.60 Million | -26.27% |
| 2020 | $574.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medical Developments International Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.19 Million USD |
| MoneyControl | $57.19 Million USD |
| MarketWatch | $57.19 Million USD |
| marketcap.company | $57.19 Million USD |
| Reuters | $57.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.